Selective small molecule histone deacetylase inhibitors to treat multiple myeloma with possible indications for inflammatory, neurodegenerative, infectious and genetic disease
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Acetylon Pharmaceuticals plus 4816 other startups.